Ares Capital: Risks You Should Not Ignore Before The Q3 Release (Archive)

Rate cuts, portfolio stresses, and rich valuation threaten Ares Capital’s future returns.

Ares Capital: Risks You Should Not Ignore Before The Q3 Release (Archive)

This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.

Elevator Pitch

  • The market is pricing in a certainty of rate cuts 6 months out. This is not good for ARCC as it can shrink its investment less interest cost spreads further.
  • Elevated interest receivables is another risk to monitor carefully. It may signal trouble brewing in the portfolio and undermine the quality of the net investment income earnings.
  • ARCC is trading at a higher-than-usual premium vs the broader BDC sector on a 1-yr fwd PE basis. This introduces risks of relative overvaluation.
  • ARCC vs. SP500 is making its way down toward the bottom of a big range on the 4-monthly ratio charts.
  • M&A data suggests a low deal activity environment, but the upside risk here is that more recent management commentary suggests a recovery.

Read the full article here.

Disclosures and Disclaimers

Past performance ≠ future results. Not investment advice. See full Disclaimer.